FAS and head and neck cancer: In head and neck cancer, treatment with phosphatase inhibitor or silencing of FAP-1 abolishes their resistance to apoptosis, suggesting that FAP-1 activity could be responsible for NF-κB activation and resistance of cells to Fas-mediated apoptosis [57].